NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ t-cell-mediated immunity and protection against NY-ESO-1+ tumors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples